Info for medical societies

Navigation

Shopping cart

Shopping cart is empty.

View cart

American Academy of Neurology

Anticoagulants and antiplatelet agents in acute ischemic stroke

Category: Critical Care, Emergency Medicine, Neurology
Conditions: Acute ischemic stroke (cardioembolic large vessel atherosclerotic vertebrobasilar or """"progressing"""" stroke)
Published Date: 2002 Jul (reviewed 2005 Oct)
Published by: American Academy of Neurology, American Stroke Association

Pocket Card

PDA Version

FALSE

FDA Warning

Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)

Category:
Conditions: Movement disorders:BlepharospasmHemifacial spasmCervical dystonia (CD)Focal limb dystoniaLaryngeal dystoniaTics (e.g. motor phonic)Tremor
Published Date: 2008 May 6
Published by: American Academy of Neurology

Pocket Card

PDA Version

1

FDA Warning

Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review)

Category:
Conditions: Adult spasticity and spasticity in pediatric cerebral palsy
Published Date: 2008 May 6
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review)

Category:
Conditions: Hypersecretory disordersAxillary hyperhidrosisPalmer hyperhidrosisGustatory sweatingDrooling in neurodegenerative diseasesHyperlacrimationNeuro-urologic disordersDetrusor sphincter dyssynergiaNeurogenic detrusor overactivityLow back painHeadacheEpisodic migraineChronic daily headacheChronic tension-type headache
Published Date: 2008 May 6
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Assessment: prevention of post-lumbar puncture headaches

Category:
Conditions: Post-lumbar puncture headache
Published Date: 2000 Oct (revised 2005 Aug)
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review)

Category:
Conditions: Multiple sclerosis (MS) including:Relapsing remitting MS (RRMS)Secondary progressive MS (SPMS)
Published Date: 2008 Sep 2
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Assessment: transcranial Doppler ultrasonography

Category:
Conditions: Stroke in children with sickle cell diseaseRight-to-left cardiac shuntsIntracranial steno-occlusive diseaseOcclusion of the middle cerebral artery intracranial artery vertebral artery basilar artery (acute cerebral infarction)Extracranial internal carotid artery (ICA) stenosisCerebral microembolizationReocclusion or recanalization during central thrombolysisVasospasm after spontaneous subarachnoid hemorrhageVasospasm after traumatic subarachnoid hemorrhageCerebral circulatory arrest and brain deathIntracerebral hemorrhageStroke following coronary artery bypass surgeryStroke following carotid endarterectomy
Published Date: 2004 May 11
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Assessment: use of epidural steroid injections to treat radicular lumbosacral pain

Category:
Conditions: Radicular lumbosacral pain (sciatica)
Published Date: 2007 Mar 6
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Carotid endarterectomy- an evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Category:
Conditions: Carotid artery stenosisStroke
Published Date: 2005 Sep
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Category:
Conditions: Multiple sclerosis
Published Date: 2002 Jan 22 (reviewed 2003 Oct)
Published by: American Academy of Neurology, Multiple Sclerosis Council

Pocket Card

PDA Version

0

FDA Warning

Evidence report the medical treatment of ocular myasthenia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Ocular myasthenia
Published Date: 2007 Jun 12
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Immunization and multiple sclerosis: a summary of published evidence and recommendations

Category:
Conditions: Multiple sclerosis (MS) exacerbations after vaccine-preventable infectious episodesMultiple sclerosis exacerbations after immunizations
Published Date: 2002 Dec 24 (reviewed 2006 Dec)
Published by: American Academy of Neurology, Multiple Sclerosis Council

Pocket Card

PDA Version

0

FDA Warning

Practice advisory the use of felbamate in the treatment of patients with intractable epilepsy: a report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Category:
Conditions: Intractable epilepsy
Published Date: 1999 May (reviewed 2006 Oct)
Published by: American Academy of Neurology, American Epilepsy Society

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Seizures (convulsions) associated with primary or metastatic brain tumors (brain neoplasms)
Published Date: 2000 May (reviewed 2003)
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Traumatic brain injurySeizures
Published Date: 2003 Jan 14
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: assessing patients in a neurology practice for risk of falls: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Neurologic or general conditions associated with an increased risk of falling including:Muscle weaknessDeficits in gait or balanceVisual deficitsArthritisImpairments in activities of daily livingDepressionCognitive impairment
Published Date: 2008 Feb 5
Published by: American Academy of Neurology

Pocket Card

PDA Version

1

FDA Warning

Practice parameter: diagnosis of dementia: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Dementia including vascular dementia dementia with Lewy bodies and frontotemporal dementia Creutzfeldt-Jakob diseaseAlzheimer???s disease
Published Date: 2001 May (reviewed 2004)
Published by: American Academy of Neurology

Pocket Card

PDA Version

1

FDA Warning

Practice parameter: diagnostic assessment of the child with status epilepticus: an evidence-based review

Category:
Conditions: Status epilepticus
Published Date: 2006 Nov
Published by: American Academy of Neurology, Child Neurology Society

Pocket Card

PDA Version

1

FDA Warning

Practice parameter: early detection of dementia: mild cognitive impairment: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: DementiaAlzheimer???s disease
Published Date: 2001 May (reviewed 2003)
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: evaluating a first nonfebrile seizure in children. Report of the Quality Standards Subcommittee of the American Academy of Neurology the Child Neurology Society and the American Epilepsy Society

Category:
Conditions: First nonfebrile seizure in children including partial (simple or complex partial or partial with secondary generalization) generalized clonic or tonic seizures.
Published Date: 2000 Sep (reviewed 2006 Jul)
Published by: American Academy of Neurology, American Epilepsy Society

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: evaluating an apparent unprovoked first seizure in adults: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

Category:
Conditions: Unprovoked first seizureNote: First seizure is defined as to include a single seizure or multiple seizures within 24 hours with recovery of consciousness between the seizures.
Published Date: 2007 Nov 20
Published by: American Academy of Neurology, American Epilepsy Society

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: evaluation of children and adolescents with recurrent headaches. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

Category:
Conditions: Recurrent headaches unassociated with trauma fever or other obvious provocative causes
Published Date: 2002 Aug 27 (reviewed 2005 Oct)
Published by: American Academy of Neurology, Child Neurology Society

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: evaluation of the child with global developmental delay. Report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society

Category:
Conditions: Non-progressive global developmental delay
Published Date: 2003 Feb 11
Published by: American Academy of Neurology, Child Neurology Society

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: immunotherapy for Guillain-Barre syndrome. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Guillain-Barre syndrome
Published Date: 2003 Sep 23
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review

Category:
Conditions: Parkinson???s disease
Published Date: 2002 Jan 8 (reviewed 2005 Oct)
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: medical treatment of infantile spasms. Report of the American Academy of Neurology and the Child Neurology Society

Category:
Conditions: Infantile spasms
Published Date: 2004 May 25
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: neuroimaging of the neonate. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

Category:
Conditions: Conditions that may require neuroimaging of the neonate such as:Very low birth weight (preterm)Neonatal encephalopathy
Published Date: 2002 Jun 25 (reviewed 2005 Oct)
Published by: American Academy of Neurology, Child Neurology Society

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: StrokePatent foramen ovale (PFO)Atrial septal aneurysm (ASA)
Published Date: 2004 Apr 13
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: screening and diagnosis of autism. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society

Category:
Conditions: Autism (also known as autistic spectrum disorder)
Published Date: 2000 Aug (reviewed 2006 Jul)
Published by: American Academy of Neurology, Child Neurology Society

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology in association with the American Epilepsy Society and the American Association of Neurol

Category:
Conditions: Disabling complex partial seizures associated with epilepsy
Published Date: 2003 Feb 25
Published by: American Academy of Neurology, American Association of Neurological Surgeons

Pocket Card

PDA Version

1

FDA Warning

Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies

Category:
Conditions: Trigeminal neuralgia (TN)Classic TN (CTN)Symptomatic TN (STN)
Published Date: 2008 Oct 7
Published by: American Academy of Neurology, European Federation of Neurological Societies

Pocket Card

PDA Version

1

FDA Warning

Practice parameter: therapies for benign paroxysmal positional vertigo: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Benign paroxysmal positional vertigo (BPPV)
Published Date: 2008 May 27
Published by: American Academy of Neurology

Pocket Card

PDA Version

1

FDA Warning

Practice parameter: therapies for essential tremor. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Essential tremor (ET)
Published Date: 2005 Jun
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: thymectomy for autoimmune myasthenia gravis: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Nonthymomatous autoimmune myasthenia gravis
Published Date: 2000 Jul (reviewed 2006 Oct)
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: treatment of nervous system Lyme disease: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Nervous system Lyme disease includingMeningitis cranial neuritis and radiculoneuritisParenchymal inflammation of the brain or spinal cordMild radiculoneuropathy presenting as diffuse predominantly sensory peripheral neuropathyEncephalopathyPost-Lyme syndrome
Published Date: 2007 Jul
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

Category:
Conditions: Postherpetic neuralgia
Published Date: 2004 Sep
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Practice parameter: treatment of the child with a first unprovoked seizure. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

Category:
Conditions: First time unprovoked seizures including partial seizures as well as generalized onset tonic-clonic or tonic seizures (not including absence myoclonic and atonic seizures)
Published Date: 2003 Jan 28
Published by: American Academy of Neurology, Child Neurology Society

Pocket Card

PDA Version

0

FDA Warning

Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Category:
Conditions: Conditions of sensory dysfunction for which quantitative sensory testing may have clinical utility including:Diabetic neuropathySmall fiber sensory neuropathyPain syndromesToxic neuropathiesUremic neuropathyAcquired and inherited demyelinating neuropathiesPsychogenic sensory loss and malingering
Published Date: 2003 Mar 25
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

Reassessment: neuroimaging in the emergency patient presenting with seizure (an evidence-based review)

Category:
Conditions: Seizure
Published Date: 1996 (revised 2007 Oct)
Published by: American Academy of Neurology

Pocket Card

PDA Version

0

FDA Warning

The utility of MRI in suspected multiple sclerosis (MS): report of the Therapeutics and Technology Assessment

Category:
Conditions: Multiple sclerosis
Published Date: 2003 Sep 9
Published by: American Academy of Neurology, Child Neurology Society

Pocket Card

PDA Version

0

FDA Warning

Use of serum prolactin in diagnosing epileptic seizures: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Category:
Conditions: Epileptic seizures including generalized tonic-clonic seizures and complex partial seizuresPsychogenic nonepileptic seizuresSyncopeStatus epilepticusRepetitive seizuresNeonatal seizures
Published Date: 2005 Sep
Published by: American Academy of Neurology

Pocket Card

PDA Version

1

FDA Warning